[1]
P. Mancino, K. Falasca, C. Ucciferri, E. Pizzigallo, and J. Vecchiet, “USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS”, Mediterr J Hematol Infect Dis, vol. 2, no. 1, p. e2010003, Mar. 2010.